Poseida Therapeutics said that 21 of 23 patients (91%) responded to the allogeneic CAR-T therapy it’s developing with Roche ...

Kezar Life Sciences is suspending enrollment and dosing in a lupus trial after four patients died in the mid-stage study of ...

DCVC Bio confirmed it has put together a $400 million third fund, four years after raising $350 million in its sophomore ...

Prime Medicine announced Monday morning that it is cutting its pipeline, and it signed a T cell therapy partnership with ...

Roche is spending $850 million upfront to buy Regor Pharmaceuticals’ suite of next-generation CDK inhibitors as it doubles ...

As other young radiopharmaceutical companies get acquired by drugmakers, Boston-based Aktis Oncology wants to become one of ...

Johnson & Johnson and Legend Biotech's CAR-T cell therapy Carvykti reduced the risk of death by 45% compared to standard of ...

The federal government renewed its threats to Johnson & Johnson on Friday over the company’s proposal to change how some ...

Novo Nordisk has told government and global nonprofits that it plans to significantly downsize its manufacturing of some of ...